Amneal Pharmaceuticals, Inc. ($AMRX)
Filing Information
| Accession Number | 0001628280-26-032925 |
|---|---|
| Form Type | 4 |
| Filing Date | May 8, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
89,462
Total Value
$0.00
P&L
+inf% (+$249,782.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Class A Common Stock | โ | May 7, 2026 | Exercise/Conversion | 34,819 | โ | โ | 128,479 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | May 7, 2026 | Exercise/Conversion | 34,819 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | May 6, 2026 | Grant/Award | 19,824 | $0.00 | $0.00 | 19,824 | Direct | โ | View Details |